TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | -1 | 1 | 0 | 0 | 0 | 0 | 0 |
| S | %wins | 100 | 0 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/1/22 17:09 | 7/28/22 | ARE | Alexandria Real Estate Equities, Inc. | MD | RlEst | REIT | Real Estate Investment Trusts | Freire Maria C | CA | D | S.m | -424 | 163.21 | 0 | -3 | -49 | 3 | D | |||||||||||||||
5/17/21 20:15 | 5/11/21 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Freire Maria C | CA | D | S | -207 | 25.01 | 0 | -8 | -21 | 32 | D | |||||||||||||||
2/19/20 16:23 | 2/14/20 | ARE | Alexandria Real Estate Equities, Inc. | MD | RlEst | REIT | Real Estate Investment Trusts | Freire Maria C | CA | D | S | -255 | 174.20 | 0 | -1 | -29 | 4 | D | |||||||||||||||
8/20/18 17:16 | 8/16/18 | ARE | Alexandria Real Estate Equities Inc | MD | RlEst | REIT | Real Estate Investment Trusts | Freire Maria C | CA | D | S | -386 | 128.67 | 0 | -3 | -47 | 3 | D | |||||||||||||||
5/8/17 16:20 | 5/4/17 | ARE | Alexandria Real Estate Equities Inc | MD | RlEst | REIT | Real Estate Investment Trusts | Freire Maria C | CA | D | S | -246 | 113.30 | 33 | -2 | -28 | 5 | D | 35 | 24 | 12 | 5 | 4 | 0 | 1 | 0 | -1 | 1 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |